Riskpilot← Back to searchSign inGet full accessPKxpert AB
ABActiveOrg 5569259301Norra Vallgatan 20Engineering activities and related technical consultancy · NACE 7112Est. 20132 employees
Revenue 2025
SEK 3,7M
-27% vs 2024
EBITDA margin
30.5%
-51% vs 2024
Equity ratio
56.4%
Financial strength
Net profit 2025
SEK 714K
-57% vs 2024
| Revenue | SEK 3,7M | -27% |
| EBITDA | SEK 1,1M | -51% |
| Net profit | SEK 714K | -57% |
| Total assets | SEK 3,7M | +4% |
| Equity | SEK 2,1M | -2% |
| Employees | 2 | — |
Legal name
PKxpert AB
Org number
5569259301
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
14 mars 2013
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget kommer att bedriva vetenskaplig rådgivning, dvs konsultverksamhet inom läkemedelsutvecklingsbranschen. Ägaren har specialistkompetens inom området farmakokinetik (vedertagen förkortning inom branschen är PK).
Address
Norra Vallgatan 20
Email
annsofi.nihlen@pkxpert.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 924 | 3 273 | 3 284 | 5 045 | 3 708 |
| Staff expenses | — | −1 808 | −1 888 | −2 032 | −2 056 |
| EBITDA | 1 619 | 771 | 833 | 2 314 | 1 129 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 1 619 | 771 | 833 | 2 314 | 1 129 |
| Net financials | 1 | 1 | 3 | 16 | 19 |
| Profit before tax | 1 212 | 1 014 | 864 | 2 080 | 906 |
| Tax | −252 | −214 | −185 | −436 | −193 |
| Net profit | 960 | 800 | 679 | 1 643 | 714 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 562 | 2 156 | 2 137 | 3 513 | 3 652 |
| Equity | 1 103 | 1 103 | 1 122 | 2 106 | 2 059 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 312 | 148 | 138 | 280 | 224 |
| Total debt | 312 | 148 | 138 | 280 | 224 |
EBITDA margin
30.5%
This company
15.8%
Market median
+93% vs market
20212025
Equity ratio
56.4%
This company
38.2%
Market median
+48% vs market
20212025
Return on equity
34.7%
This company
18.4%
Market median
+89% vs market
20212025
Net profit margin
19.2%
This company
8.1%
Market median
+137% vs market
20212025
Asset turnover
1.02×
This company
1.12×
Market median
+9% vs market
20212025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ST Chief Auditor | Chief Auditor | 2022 |
KA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PKxpert AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Theresa Meijer | Chief Auditor | 0 companies |
| Karin Annsofi Nihlén | Chief Executive Officer | 0 companies |
| Achim Nihlén Orzechowski | Deputy Board Member | 0 companies |